 Jesse Davidson
Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiopulmonary Bypass | 12 | 2023 | 203 | 6.720 |
Why?
| | Alkaline Phosphatase | 6 | 2019 | 157 | 3.010 |
Why?
| | Cardiac Surgical Procedures | 6 | 2022 | 461 | 2.810 |
Why?
| | Heart Defects, Congenital | 5 | 2023 | 703 | 2.310 |
Why?
| | Postoperative Complications | 8 | 2021 | 2235 | 1.490 |
Why?
| | Acute Kidney Injury | 3 | 2022 | 709 | 1.420 |
Why?
| | Endothelin-1 | 2 | 2022 | 168 | 1.350 |
Why?
| | Heart Arrest | 3 | 2020 | 291 | 1.230 |
Why?
| | Adenosine | 2 | 2018 | 211 | 1.060 |
Why?
| | Kynurenine | 2 | 2021 | 81 | 0.920 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 28 | 0.920 |
Why?
| | Tryptophan | 2 | 2022 | 139 | 0.910 |
Why?
| | Infant | 16 | 2022 | 8293 | 0.890 |
Why?
| | Swine | 5 | 2023 | 730 | 0.860 |
Why?
| | Oxylipins | 1 | 2022 | 28 | 0.850 |
Why?
| | Heart Bypass, Right | 1 | 2022 | 15 | 0.850 |
Why?
| | Fetal Diseases | 1 | 2023 | 148 | 0.840 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 106 | 0.830 |
Why?
| | Arrhythmias, Cardiac | 2 | 2020 | 277 | 0.780 |
Why?
| | Prospective Studies | 11 | 2022 | 6471 | 0.760 |
Why?
| | Metabolomics | 3 | 2021 | 550 | 0.750 |
Why?
| | Biomarkers | 7 | 2023 | 3588 | 0.710 |
Why?
| | Coronary Care Units | 1 | 2018 | 14 | 0.680 |
Why?
| | Interleukin-1 Receptor-Like 1 Protein | 1 | 2019 | 24 | 0.680 |
Why?
| | Length of Stay | 4 | 2018 | 1032 | 0.660 |
Why?
| | Blood Proteins | 1 | 2020 | 248 | 0.660 |
Why?
| | Fontan Procedure | 1 | 2020 | 154 | 0.650 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2019 | 107 | 0.650 |
Why?
| | Aortic Coarctation | 1 | 2019 | 57 | 0.650 |
Why?
| | Endotoxemia | 1 | 2019 | 93 | 0.640 |
Why?
| | Infant, Newborn | 9 | 2023 | 5255 | 0.630 |
Why?
| | 5'-Nucleotidase | 1 | 2018 | 34 | 0.630 |
Why?
| | Endotoxins | 1 | 2019 | 234 | 0.630 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2018 | 490 | 0.590 |
Why?
| | Ventricular Remodeling | 1 | 2019 | 229 | 0.580 |
Why?
| | Calcitonin | 2 | 2013 | 29 | 0.570 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2018 | 178 | 0.570 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 421 | 0.570 |
Why?
| | Adenosine Monophosphate | 1 | 2016 | 51 | 0.560 |
Why?
| | Postoperative Care | 2 | 2021 | 237 | 0.560 |
Why?
| | Protein Precursors | 2 | 2013 | 126 | 0.540 |
Why?
| | Ventricular Function, Left | 1 | 2019 | 468 | 0.530 |
Why?
| | Cardiotonic Agents | 2 | 2012 | 127 | 0.500 |
Why?
| | Sepsis | 3 | 2017 | 531 | 0.500 |
Why?
| | C-Reactive Protein | 2 | 2013 | 360 | 0.490 |
Why?
| | Glipizide | 1 | 2013 | 6 | 0.470 |
Why?
| | Octreotide | 1 | 2013 | 27 | 0.460 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2013 | 37 | 0.460 |
Why?
| | Sulfonylurea Compounds | 1 | 2013 | 44 | 0.460 |
Why?
| | Lung | 2 | 2022 | 3664 | 0.420 |
Why?
| | Cardiac Output, Low | 1 | 2012 | 68 | 0.420 |
Why?
| | Thoracic Surgical Procedures | 1 | 2012 | 64 | 0.410 |
Why?
| | Treatment Outcome | 8 | 2022 | 9342 | 0.410 |
Why?
| | Humans | 26 | 2023 | 118972 | 0.390 |
Why?
| | Purines | 2 | 2022 | 161 | 0.380 |
Why?
| | Vasodilator Agents | 1 | 2012 | 328 | 0.360 |
Why?
| | Kinetics | 3 | 2018 | 1624 | 0.330 |
Why?
| | Hypoglycemia | 1 | 2013 | 400 | 0.330 |
Why?
| | Postoperative Period | 2 | 2022 | 309 | 0.330 |
Why?
| | Metabolome | 2 | 2021 | 296 | 0.320 |
Why?
| | Inflammation | 2 | 2022 | 2566 | 0.300 |
Why?
| | Female | 13 | 2023 | 61564 | 0.280 |
Why?
| | Critical Care | 2 | 2021 | 492 | 0.260 |
Why?
| | Animals | 7 | 2023 | 33381 | 0.260 |
Why?
| | Hypoxia | 2 | 2022 | 963 | 0.260 |
Why?
| | Palliative Care | 2 | 2021 | 629 | 0.250 |
Why?
| | Male | 13 | 2020 | 57801 | 0.250 |
Why?
| | Cohort Studies | 3 | 2023 | 5116 | 0.240 |
Why?
| | Child | 8 | 2022 | 19129 | 0.230 |
Why?
| | Calcitonin Gene-Related Peptide | 2 | 2013 | 33 | 0.230 |
Why?
| | Prostaglandins | 1 | 2022 | 78 | 0.210 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 1 | 2022 | 18 | 0.210 |
Why?
| | Time Factors | 3 | 2019 | 6412 | 0.210 |
Why?
| | Analysis of Variance | 2 | 2016 | 1293 | 0.200 |
Why?
| | Dysbiosis | 1 | 2023 | 147 | 0.200 |
Why?
| | Models, Animal | 1 | 2023 | 363 | 0.190 |
Why?
| | Niacinamide | 1 | 2021 | 70 | 0.190 |
Why?
| | Matrix Metalloproteinase 7 | 1 | 2020 | 23 | 0.190 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 1868 | 0.190 |
Why?
| | Methionine | 1 | 2021 | 145 | 0.190 |
Why?
| | Preoperative Period | 1 | 2020 | 110 | 0.190 |
Why?
| | Heart Function Tests | 1 | 2019 | 61 | 0.180 |
Why?
| | Pulmonary Veins | 1 | 2020 | 84 | 0.180 |
Why?
| | International Classification of Diseases | 1 | 2020 | 122 | 0.170 |
Why?
| | Time | 1 | 2019 | 77 | 0.170 |
Why?
| | Chromatography, Liquid | 1 | 2020 | 355 | 0.170 |
Why?
| | Risk Factors | 4 | 2021 | 9000 | 0.170 |
Why?
| | Surgical Procedures, Operative | 1 | 2021 | 215 | 0.170 |
Why?
| | Child, Preschool | 4 | 2020 | 9491 | 0.170 |
Why?
| | Pilot Projects | 1 | 2023 | 1419 | 0.170 |
Why?
| | Serotonin | 1 | 2020 | 309 | 0.160 |
Why?
| | Matrix Metalloproteinases | 1 | 2019 | 90 | 0.160 |
Why?
| | Rewarming | 1 | 2018 | 17 | 0.160 |
Why?
| | GPI-Linked Proteins | 1 | 2018 | 56 | 0.160 |
Why?
| | Hospital Mortality | 2 | 2018 | 814 | 0.150 |
Why?
| | Respiration, Artificial | 2 | 2018 | 545 | 0.150 |
Why?
| | Mass Spectrometry | 1 | 2020 | 681 | 0.150 |
Why?
| | Heart Ventricles | 1 | 2022 | 727 | 0.140 |
Why?
| | Cardiac Catheterization | 1 | 2020 | 541 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2020 | 3171 | 0.140 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2019 | 374 | 0.140 |
Why?
| | Extracellular Space | 1 | 2016 | 127 | 0.140 |
Why?
| | Solubility | 1 | 2016 | 235 | 0.140 |
Why?
| | Intensive Care Units, Pediatric | 2 | 2017 | 157 | 0.130 |
Why?
| | Coronary Thrombosis | 1 | 2015 | 25 | 0.130 |
Why?
| | Chi-Square Distribution | 1 | 2016 | 525 | 0.130 |
Why?
| | Databases, Factual | 1 | 2020 | 1231 | 0.130 |
Why?
| | Age Factors | 2 | 2020 | 2995 | 0.130 |
Why?
| | Cytokines | 1 | 2023 | 1900 | 0.130 |
Why?
| | Proteomics | 1 | 2020 | 876 | 0.130 |
Why?
| | Kidney | 1 | 2022 | 1353 | 0.120 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2015 | 77 | 0.120 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1474 | 0.120 |
Why?
| | Prognosis | 2 | 2019 | 3443 | 0.120 |
Why?
| | Quality Improvement | 1 | 2021 | 963 | 0.120 |
Why?
| | Cattle | 1 | 2016 | 978 | 0.120 |
Why?
| | Liver Function Tests | 1 | 2013 | 107 | 0.110 |
Why?
| | Intubation | 1 | 2012 | 5 | 0.110 |
Why?
| | Algorithms | 1 | 2020 | 1541 | 0.110 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 403 | 0.110 |
Why?
| | Infusions, Intravenous | 1 | 2013 | 380 | 0.110 |
Why?
| | Logistic Models | 2 | 2020 | 1901 | 0.110 |
Why?
| | Retrospective Studies | 4 | 2021 | 12978 | 0.100 |
Why?
| | Linear Models | 1 | 2013 | 827 | 0.100 |
Why?
| | ROC Curve | 1 | 2012 | 473 | 0.090 |
Why?
| | Intubation, Intratracheal | 1 | 2012 | 226 | 0.090 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2674 | 0.090 |
Why?
| | Risk Assessment | 1 | 2018 | 3057 | 0.090 |
Why?
| | Adolescent | 4 | 2020 | 18480 | 0.080 |
Why?
| | Myocardial Infarction | 1 | 2015 | 968 | 0.080 |
Why?
| | Citalopram | 1 | 2020 | 27 | 0.050 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 51 | 0.040 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 86 | 0.040 |
Why?
| | Adult | 1 | 2020 | 31512 | 0.040 |
Why?
| | Myocardial Contraction | 1 | 2019 | 339 | 0.040 |
Why?
| | Odds Ratio | 1 | 2020 | 996 | 0.040 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2019 | 228 | 0.040 |
Why?
| | Vasoconstrictor Agents | 1 | 2017 | 122 | 0.040 |
Why?
| | Survival Rate | 1 | 2021 | 1720 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2021 | 635 | 0.040 |
Why?
| | Hemodynamics | 1 | 2019 | 1003 | 0.030 |
Why?
| | Subtilisins | 1 | 1994 | 10 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2015 | 69 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2424 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 1994 | 91 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1166 | 0.030 |
Why?
| | Lysosomes | 1 | 1994 | 136 | 0.030 |
Why?
| | Endosomes | 1 | 1994 | 128 | 0.030 |
Why?
| | Tissue Plasminogen Activator | 1 | 2015 | 231 | 0.030 |
Why?
| | Blood Pressure | 1 | 2019 | 1664 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 2015 | 238 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 1994 | 446 | 0.030 |
Why?
| | Hospitalization | 1 | 2020 | 1785 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2015 | 402 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2015 | 1284 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3174 | 0.020 |
Why?
| | Young Adult | 1 | 2020 | 10793 | 0.020 |
Why?
| | United States | 1 | 2021 | 12555 | 0.020 |
Why?
| | Immunologic Techniques | 1 | 1994 | 40 | 0.010 |
Why?
| | Furin | 1 | 1994 | 13 | 0.010 |
Why?
| | Cell Compartmentation | 1 | 1994 | 53 | 0.010 |
Why?
| | Cytoplasm | 1 | 1994 | 269 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1994 | 2071 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1994 | 2871 | 0.010 |
Why?
| | Cell Line | 1 | 1994 | 2707 | 0.010 |
Why?
| | Rats | 1 | 1994 | 5392 | 0.000 |
Why?
|
|
Davidson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|